Horacio Bach

Horacio Bach earned his PhD in Molecular Microbiology and Biotechnology from the University of Tel Aviv, studying the interactions between an esterase and the polysaccharide emulsan. Subsequently, in his first post–doctorate, he joined the laboratory of Prof. David Sherman in Minnesota, working on developing a biochip to generate novel antibiotic molecules from Streptomyces coelicolor. Dr. Bach worked for Taro Pharmaceuticals in New York, developing novel fermentation technologies and engineering organisms to produce steroids. In 2004, Dr. Bach joined the laboratory of Dr. Yossef Av-Gay at the Division of Infectious Diseases, University of British Columbia in Vancouver, Canada. He worked on the function of tyrosine phosphatases of Mycobacterium tuberculosis and the interactions within the host macrophages. Dr. Bach holds a Clinical Assistant Professor position at the same institution. His current research interests include virulence factors of human pathogens, antibody engineering, nanomedicine, and Crohn’s disease. Prof. Bach is the author of more than 130 publications, including papers, patents, reviews, and book chapters.